|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| A pilot study of three oral contraceptives in Seattle. |
| The International Fertility Research Program carried out a pilot study at the Planned Parenthood Clinic of Seattle |
| which: 1) compared Ovral Fe 28 and Norinyl 1/50 Fe 28, 2) evaluated Norlestrin 1 mg Fe 28, 3) compared side effects |
| of Norlestrin with Ovral and Norinyl, 4) assessed the effect of the switchover from 1 oral contraceptive (OC) to the |
| other, and 5) studied side effects during different periods of the contraceptive cycle. In 1972, acceptors were given 3 |
| cycles on Ovral and Norinyl and then were switched to Norlestrin which was to be used for the next 3 cycles. A |
| Systemic Contraceptive Study Admission Record was completed on each patient when she enrolled, and follow-up |
| records were completed after 3 cycles of each OC. There were about the same number of women reporting side |
| effects for both Ovral and Norinyl. 66% reported spotting or bleeding and 70% reported menstrual cramps in 1 or more |
| of 3 cycles. Other side effects reported were headache, abdominal bloating, breast discomfort, increased pain, and |
| vaginal discharge. Norinyl users reported fewer days of duration for all side effects except breast tenderness for |
| which they reported twice as many days. There was a similarity in the side effects from Norlestrin reported by the |
| women who switched from Ovral and Norinyl. Spotting or bleeding was the most frequently reported; 68% reported |
| change in flow, 42% a decrease; and a majority reported menstrual cramps, headache, abdominal bloating, |
| increased acne, and vaginal discharge. (PubHealth.info Document ID: CONT7T 3052-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "A pilot study of three oral contraceptives in Seattle.", |
| is(are) TALWAR P. The source of this article is "September 1975. 22 p.". This article was published in 1975 in |
| English language(s). (PubHealth.info® Document ID: CONT7T 3052-06. All rights reserved with PubHealth.info) PIN: |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |